Amdocs Limited (NASDAQ:DOX) Given Average Rating of “Hold” by Brokerages

Shares of Amdocs Limited (NASDAQ:DOX) have earned an average rating of “Hold” from the seven research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $86.6667.

Several analysts have recently issued reports on DOX shares. Stifel Nicolaus reduced their price objective on Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. KeyCorp started coverage on Amdocs in a research report on Monday, June 29th. They set a “sector weight” rating for the company. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Sunday, July 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Finally, Cfra cut shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th.

Amdocs Trading Down 2.5%

Shares of DOX opened at $55.29 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.98 and a quick ratio of 0.98. Amdocs has a 1-year low of $49.74 and a 1-year high of $90.29. The stock has a market cap of $5.97 billion, a price-to-earnings ratio of 11.06, a price-to-earnings-growth ratio of 0.99 and a beta of 0.40. The firm has a 50 day simple moving average of $54.54 and a 200-day simple moving average of $63.50.

Amdocs (NASDAQ:DOX) last posted its earnings results on Wednesday, August 5th. The technology company reported $1.84 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.84. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.18 billion. Amdocs had a return on equity of 19.77% and a net margin of 11.81%.Amdocs’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.72 EPS. Amdocs has set its Q4 2026 guidance at 1.940-2.000 EPS and its FY 2026 guidance at 7.374-7.444 EPS. Equities analysts forecast that Amdocs will post 6.56 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.569 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.28 annualized dividend and a dividend yield of 4.1%. Amdocs’s dividend payout ratio is presently 45.60%.

Key Stories Impacting Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Fiscal Q3 revenue increased 2.7% year over year to $1.175 billion, reaching the midpoint of management’s guidance. Managed-services revenue rose 2.5% to $791 million, while non-GAAP diluted EPS of $1.84 was at the midpoint of the company’s $1.81–$1.87 range and matched the Zacks consensus estimate. Amdocs Limited Reports Third Quarter Fiscal 2026 Results
• Positive Sentiment: Amdocs maintained its fiscal 2026 outlook, including revenue growth of 3.2%–4.0% and EPS guidance of $7.374–$7.444, above the $7.240 consensus estimate. Fourth-quarter EPS guidance of $1.940–$2.000 also brackets or exceeds expectations. Amdocs Q3 Earnings Match Estimates
• Positive Sentiment: The company announced or expanded multiple enterprise and telecommunications engagements, including projects with Liberty Latin America, Lumen, PLDT Home, Sunrise, Vivo, A1 Austria, Optimum and Brazil’s Cielo. These wins support demand for Amdocs’ cloud, AI, billing, customer-experience and connectivity platforms. Lumen Extends Multi-Cloud Strategy with Amdocs
• Neutral Sentiment: Backlog rose 2.7% year over year to $4.26 billion, and Amdocs repurchased $143 million of shares during the quarter. Free-cash-flow guidance remained $710 million–$730 million, excluding restructuring payments.
• Negative Sentiment: GAAP diluted EPS was only $0.59, affected by a $106 million restructuring charge, while GAAP operating income fell 48.4% to approximately $105 million and operating margin declined to 8.9%. Cash generation also weakened after including restructuring payments. Amdocs Q3 2026 Earnings: Revenue Growth but Profit Declines

Institutional Trading of Amdocs

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Amundi boosted its holdings in shares of Amdocs by 73.0% in the 1st quarter. Amundi now owns 13,778 shares of the technology company’s stock valued at $1,217,000 after purchasing an additional 5,816 shares during the last quarter. Millennium Management LLC raised its position in shares of Amdocs by 458.3% in the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock worth $6,135,000 after buying an additional 55,038 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Amdocs by 12.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after buying an additional 37,087 shares during the period. Empowered Funds LLC boosted its holdings in Amdocs by 12.0% in the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock valued at $1,462,000 after acquiring an additional 1,709 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock valued at $10,608,000 after acquiring an additional 76,683 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.